Catharanthine Market

Pharmaceutical is set to lead the catharanthine market at 71.0% share of end use industry in 2026, followed by catharanthine sulfate as expected at 63.0% share of product type in 2026. Adoption is driven by pharmaceutical-manufacturing demand and specification consistency, with supplier qualification and documentation requirements forming principal barriers.